FDA Okays Prostate Combo Drug

(Reuters) UPDATED 2010-06-17

The U.S. Food and Drug Administration (FDA) has approved a combination drug for the treatment of prostate enlargement. Drugmaker Glaxo's Jalyn is a combination of the drugs Avodart and Flomax, both of which are already approved treatments.
Read full story >

See all Prostate News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

FDA Okays Prostate Combo Drug

People who read this also read...

What the community is saying...

Prostate Cancer: Radiation Therapy Options

Jay Motola